JHS Svendgaard Laboratories Share Price

JHS Sven.Lab.

CMP as on 14-Oct-21 15:51

₹ 26.65
0.15 0.57%

Open

₹ 27.20

Turnover (lac)

₹ 40

Prev. Close

₹ 26.50

Day's Vol (shares)

₹ 1,49,174

Day's Range (₹)

₹ 26.25
₹ 27.20

CMP as on14-Oct-21 15:34

₹ 26.60
0.2 0.76%

Open

₹ 26.90

Turnover (lac)

₹ 1

Prev. Close

₹ 26.40

Day's Vol (shares)

₹ 23,992

Day's Range

₹ 26.25
₹ 27.25

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 03-Aug-2021 - -
JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that a meeting of the Board of Directors of JHS Svendgaard Laboratories Limited (the Company) is scheduled to be held on Tuesday, 10 August, 2021 via video conferencing, inter-alia, to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended June 30, 2021. In this connection, as per the Companys Code of Practices & Procedures for fair Disclosure of Unpublished Price Sensitive Information pursuant to SEBI (Prohibition of Insider Trading), Regulations, 2015 the Trading window for dealing in securities of the Company will remain closed for all Insiders from July 01, 2021, till 48 hours after the declaration of such financial results (both days inclusive). Further, the copy of the notice is also available on the website of the Company i.e. https://www.svendgaard.com. In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations, 2015), we wish to inform.your good office that the Board of Directors of JHS Svendgaard Laboratories Limited (the Company) at their meeting held today i.e. on Tuesday, 10 August, 2021 has, inter alia, considered and approved: 1. Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30 June, 2021 2. Appointment of Mr. Neeraj Kumar as Joint CFO of the Company w.e.f 10 August,2021 The meeting of the Board of Directors commenced at 12:20 PM and concluded at 2:20 PM. Copy such Results along with Limited Review Reports thereon are enclosed as Annexure - A. Further, the brief details of the Joint Chief Financial Officer as mentioned in item no. 2 is enclosed in Annexure - B. (As Per BSE Announcement dated on 10.08.2021)
Board Meeting - 14-Jun-2021 - -
JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/06/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that a meeting of the Board of Directors of JHS Svendgaard Laboratories Limited (the Company) is scheduled to be held on Tuesday, 22nd June, 2021 via video conferencing, inter-alia, to consider and approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter & year ended March 31, 2021. In this connection, as per the Companys Code of Practices & Procedures for fair Disclosure of Unpublished Price Sensitive Information pursuant to SEBI (Prohibition of Insider Trading), Regulations, 2015 the Trading window for dealing in securities of the Company will remain closed for all Insiders from April 01, 2021, till 48 hours after the declaration of such financial results (both days inclusive). Further, the copy of the notice is also available on the website of the Company i.e. https://www.svendgaard.com. In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations, 2015), we wish to inform your good office that the Board of Directors of JHS Svendgaard Laboratories Limited (the Company) at their meeting held today i.e. on Tuesday, June 22, 2021 has, inter alia, considered and approved the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended on March 31, 2021. The meeting of the Board of Directors commenced at 12:54 P.M. and concluded at 03:15 P.M. A Copy such Results along with Audit Reports thereon are enclosed as Annexure - A, M/s S.N, Dhawan & Co. LLP, Chartered Accountants, the Statutory Auditors of the Company have issued auditors reports with an unmodified opinion on the financial results. These results are also being made available on the website of the Company at https://www.svendgaard.com. (As Per BSE Announcement dated on 22.06.2021)
Board Meeting - 01-Feb-2021 - -
JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that a meeting of the Board of Directors of JHS Svendgaard Laboratories Limited (the Company) is scheduled to be held on Tuesday, 09th February, 2021, inter-alia, to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter & nine months ended December 31, 2020. In this connection, as per the Companys Code of Practices & Procedures for fair Disclosure of Unpublished Price Sensitive Information pursuant to SEBI (Prohibition of Insider Trading), Regulations, 2015 the Trading window for dealing in securities of the Company for all Insiders, which is closed from 1st January, 20201, will remain closed till 48 hours after the announcement of outcome of the Board Meeting (both days inclusive). In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations, 2015), we wish to inform your good office that the Board of Directors of the Company, JHS Svendgaard Laboratories Limited, at their meeting held today i.e., Tuesday, February 09, 2021, at New Delhi, has, inter alia, considered and approved the: I. Unaudited Financial Results (Standalone as well as Consolidated) of the Company for the quarter and nine months ended on December 31, 2020. Copies of the such results along with Limited Review Reports thereon are enclosed as Annexure - A. II. Allotment of 35,00,000 (Thirty-Five Lakh) Equity Shares of face value of Rs. 10/- each pursuant to conversion of 35,00,000 Fully Convertible Warrants (Warrants), issued as on September 22, 2020 at an issue price of Rs. 20/- each, by way of preferential allotment on a private placement basis, to the persons belonging to Non-Promoter category: In accordance with Regulation 30 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations, 2015), we wish to inform your good office that the Board of Directors of the Company, JHS Svendgaard Laboratories Limited, at their meeting held today i.e., Tuesday, February 09, 2021, at New Delhi, has, inter alia, considered and approved the: I. Unaudited Financial Results (Standalone as well as Consolidated) of the Company for the quarter and nine months ended on December 31, 2020. Copies of the such results along with Limited Review Reports thereon are enclosed as Annexure - A. II. Allotment of 35,00,000 (Thirty-Five Lakh) Equity Shares of face value of Rs. 10/- each pursuant to conversion of 35,00,000 Fully Convertible Warrants (Warrants), issued as on September 22, 2020 at an issue price of Rs. 20/- each, by way of preferential allotment on a private placement basis, to the persons belonging to Non-Promoter category: (AS Per BSE Announcement Dated on 09.02.2021)
Board Meeting - 27-Oct-2020 - -
JHS SVENDGAARD LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, this is to inform you that a meeting of the Board of Directors of JHS Svendgaard Laboratories Limited (the Company) is scheduled to be held on Tuesday, 3rd November, 2020 (at Shorter Notice) via video conferencing, inter-alia, to consider and approve the Un-Audited Financial Results (Standalone & Consolidated) of the Company for the quarter & half year ended September 30, 2020. In this connection, as per the Companys Code of Practices & Procedures for fair Disclosure of Unpublished Price Sensitive Information pursuant to SEBI (Prohibition of Insider Trading), Regulations, 2015 the Trading window for dealing in securities of the Company will remain closed for all Insiders from 1st October, 2020 till 48 hours after the announcement of outcome of the Board Meeting (both days inclusive). Pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of JHS SVENDGAARD LABORATORIES LTD (the Company), at their meeting held today, i.e. on November 03, 2020 (commenced at [12:00] PM and concluded at [03:45 ] PM), has, inter- alia, approved the Standalone & Consolidated Un-Audited Financial Results (UFRs) for the quarter & half year ended on September 30, 2020 and taken on record the Limited Review Reports (LRRs) on such UFRs. Copies of duly such signed UFRs (Standalone and Consolidated) for the quarter & half year ended on September 30, 2020 along with the LRRs thereon are enclosed herewith. Further, the aforesaid information is also being made available on the website of the Company at www.svendgaard.com. Pursuant to Regulation 30 and 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of JHS SVENDGAARD LABORATORIES LTD (the Company), at their meeting held today, i.e. on November 03, 2020 (commenced at [12:00] PM and concluded at [03:45] PM), has, inter- alia, approved the Standalone & Consolidated Un-Audited Financial Results (UFRs) for the quarter & half year ended on September 30, 2020 and taken on record the Limited Review Reports (LRRs) on such UFRs. Copies of duly such signed UFRs (Standalone and Consolidated) for the quarter & half year ended on September 30, 2020 along with the LRRs thereon are enclosed herewith. Further, the aforesaid information is also being made available on the website of the Company at www.svendgaard.com. (AS Per BSE Announcement Dated on 03.11.2020)
Open ZERO Brokerage Demat Account